ANI PHARMACEUTICALS INC

ANIP

$1.30B

Small Cap

NASDAQPharmaceutical Preparations🇺🇸North AmericaPRINCETON897 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Aug 14, 2026

Market Overview

Stock performance and key metrics

ANIP News

Catalyst Timeline

1 upcoming, 0 past

No catalysts found.

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How ANIP's past catalysts played out

earningsJan 2026+11%earningsMar 2022-19%earningsNov 2021+50%

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is ANI PHARMACEUTICALS INC's next FDA catalyst?→

ANI PHARMACEUTICALS INC's (ANIP) next tracked catalyst is a Earnings expected August 14, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ANIP biotech catalysts?→

Add ANIP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ANI PHARMACEUTICALS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply